![](/img/cover-not-exists.png)
R02Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: an exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study
Franceschi, E., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Clavarezza, M., Maiello, E., Carteni, G., Rosti, G., Agati, R., Tosoni, A., Proietti, E., Paccapelo, A., Brandes, A.A.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv348.02
Date:
October, 2015
File:
PDF, 34 KB
english, 2015